Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1

Conditions

Leukemia, Myeloid, Acute 30Myelodysplastic Syndromes 23Precursor Cell Lymphoblastic Leukemia-Lymphoma 20Multiple Myeloma 9Leukemia, Myelomonocytic, Chronic 9Primary Myelofibrosis 8Lymphoma, Non-Hodgkin 7Leukemia, Biphenotypic, Acute 7Neuroblastoma 6Myeloproliferative Disorders 6Lymphoma 6Hodgkin Disease 6Burkitt Lymphoma 6Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 5Leukemia, Myelogenous, Chronic, BCR-ABL Positive 5Leukemia, Lymphocytic, Chronic, B-Cell 5Lymphoma, Large B-Cell, Diffuse 4Ganglioneuroblastoma 4Polycythemia Vera 3Lymphoma, Mantle-Cell 3Lymphoma, Follicular 3Leukemia 3Hematologic Neoplasms 3Thrombocythemia, Essential 2Rhabdomyosarcoma 2Lymphoma, Large-Cell, Anaplastic 2Lymphoma, B-Cell, Marginal Zone 2Graft vs Host Disease 2Anemia, Aplastic 2Wilms Tumor 1

Interventions

thymoglobulin 1fludarabine phosphate 1fludarabine 1Whole-Body Irradiation 1Stem Cell Transplantation 1Sirolimus 1Mycophenolic Acid 1Hematopoietic Stem Cell Transplantation 1Cyclophosphamide 1Antilymphocyte Serum 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Non-Malignant Neoplasm × Stem Cell Transplantation × 1 year × Clear all
NCT04083183 2025-12-18

Total Body Irradiation and Astatine-211-Labeled BC8-B10 Monoclonal Antibody for the Treatment of Nonmalignant Diseases

Fred Hutchinson Cancer Center

Phase 1/2 Recruiting
40 enrolled
Other neoplasm

Non-Malignant Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon âš¡